UConn Stem Cell Line Goes Global | February 25, 2014
By David Bauman
The University of Connecticut recently signed an agreement with a global supplier of biological research tools to market stem cells developed here to investigators studying genetic disorders around the world.
The partnership with KeraFAST will ease the way for other institutions to obtain the cell lines, resulting in more widespread use in the research community, according to Marc Lalande, executive director of Genomics and Personalized Medicine Programs at UConn, and director for both the UConn Stem Cell Institute and the Institute for Systems Genomics. More…